Variables | Patients with CrAg titers of 1:10 (N = 51) | Patients with CrAg titers of 1:5 (N = 47) | Patients with CrAg titers of 1:2 (N = 54) |
---|---|---|---|
Age, median year (range) | 51 (21–74) | 51 (24–84) | 52.5 (20–88) |
Sex, Female | 13 (25.5) | 22 (46.8) | 22 (40.7) |
Predisposing factorsa | 15 (29.4) | 18 (38.3) | 23 (42.6) |
Autoimmune diseases | 5 (9.8) | 7 (14.9) | 8 (14.8) |
Corticosteroids or immunosuppressants administrations | 7 (13.7) | 5 (10.6) | 10 (18.5) |
Haematological malignancy | 3 (5.9) | 3 (6.4) | 3 (5.6) |
Lung cancer | 2 (3.9) | 2 (4.3) | 3 (5.6) |
Type 2 diabetes mellitus | 0 (0.0) | 1 (2.1) | 3 (5.6) |
Decompensated liver cirrhosis | 0 (0.0) | 1 (2.1) | 1 (2.1) |
Signs and symptoms | |||
Cough | 21 (41.2) | 16 (34.0) | 17 (31.5) |
Shortness | 1 (2.0) | 1 (2.1) | 2 (3.7) |
Haemoptysis | 2 (3.9) | 0 (0.0) | 1 (1.9) |
Chest pain | 9 (17.6) | 4 (8.5) | 5 (9.3) |
Fever | 7 (13.7) | 6 (12.8) | 8 (14.8) |
Headache or dizziness | 6 (11.8) | 3 (6.4) | 6 (11.1) |
Fatigue | 1 (1.9) | 5 (10.6) | 2 (3.7) |
Abdominal distention | 0 (0.0) | 1 (2.1) | 0 (0.0) |
Diagnosisb | |||
Proven | 12 (23.5) | 10 (21.3) | 7 (13.0) |
Probable | 32 (62.7) | 24 (51.1) | 23 (42.6) |
Possible | 7 (13.7) | 10 (21.3) | 17 (31.5) |
Non-cryptococcosis | 0 (0.0) | 3 (6.4) | 7 (13.0) |